Is Compliance With EU Medtech Directive Really No Defence In Product Liability/Negligence Claims?
This article was originally published in SRA
What is the interplay between regulatory requirements and liability associated with alleged defects in medical devices in the EU and how is this interplay set to change? These are questions that John Leadley, Neil O'Flaherty and William Jones of the law firm of Baker & McKenzie explore here.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.